Related Experiment Videos
Regulation of BRCA1 expression by the Rb-E2F pathway
A Wang1, R Schneider-Broussard, A P Kumar
1Department of Carcinogenesis, University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957, USA.
The Journal of Biological Chemistry
|February 8, 2000
Summary
The retinoblastoma (Rb) protein regulates breast cancer susceptibility gene 1 (BRCA1) expression by controlling E2F activity. This discovery links Rb and BRCA1 tumor suppressors, offering insights into cancer development mechanisms.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Mutant alleles of BRCA1 increase breast and ovarian cancer risk.
- Mutant alleles of RB1 cause retinoblastoma and osteosarcoma.
- Both genes are frequently altered in sporadic cancers.
Purpose of the Study:
- To investigate the regulatory relationship between the RB1 gene product (Rb) and BRCA1 expression.
- To determine if Rb modulates BRCA1 expression via E2F transcriptional activity.
Main Methods:
- Utilized a transgenic mouse model to identify Brca1 as an in vivo target of E2F1.
- Analyzed the Brca1 promoter for E2F DNA-binding sites.
- Investigated the effects of cyclin D1, Cdk4, and p16(INK4a) on Brca1 promoter activity.
- Examined the human BRCA1 promoter for conserved E2F sites and regulation by E2F1 and Rb.
Main Results:
- Rb regulates murine Brca1 and human BRCA1 gene expression by modulating E2F activity.
- Brca1 is an in vivo target of E2F1.
- The Brca1 promoter contains E2F sites mediating activation by E2F1 and repression by Rb.
- Cyclin D1/Cdk4 stimulate the Brca1 promoter in an E2F-dependent manner, inhibited by p16(INK4a).
- The human BRCA1 promoter shares conserved E2F sites and similar regulation by E2F1 and Rb.
Conclusions:
- Establishes a functional link between BRCA1 and Rb tumor suppressors.
- Provides potential insights into how BRCA1 inactivation contributes to cancer development.